C

Claire Roddie

Cancer Institute (WIA)

ORCID: 0000-0002-4901-5858

Publishes on CAR-T cell therapy research, Acute Lymphoblastic Leukemia research, Lymphoma Diagnosis and Treatment. 171 papers and 5.9k citations.

PubIndex Score98Top 2% · mid-careerHow it's scored

171Publications

5.9kTotal Citations

First publication: 2006First senior author: 2021

CAR-T cell therapy research Acute Lymphoblastic Leukemia research Lymphoma Diagnosis and Treatment Biosimilars and Bioanalytical Methods Virus-based gene therapy research

Top publicationsby citations

CAR-T cell manufacturing landscape—Lessons from the past decade and considerations for early clinical development

Juliana Dias, Claire Roddie|Molecular Therapy — Methods & Clinical Development|2024

Cited by 76

Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCL

Michael Northend, William Townsend, Shalal Sadullah et al.|Blood Advances|2022

Cited by 44

Obecabtagene autoleucel (obe-cel) for Adult Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL): Deep Molecular Remission May Predict Better Outcomes

Elias Jabbour, Claire Roddie, Jae H. Park et al.|Blood|2024

Cited by 3

Deep Molecular Remission Predicts Better Clinical Outcomes in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) Treated with Obecabtagene Autoleucel (obe-cel)

Elias Jabbour, Claire Roddie, Jae H. Park et al.|Transplantation and Cellular Therapy|2025

Cited by 2